Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)
暂无分享,去创建一个
Michael L. Wang | S. Lonial | N. Raje | J. Kaufman | A. Nooka | A. Yee | Sheeba K. Thomas | J. Shah | D. Weber | D. Avigan | E. O’Donnell